Other Team Members

ex. Nurses, case managers, medical assistants, office managers

Rural Telehealth Toolkit

This toolkit compiles evidence-based and promising models and resources to support organizations in identifying and implementing telehealth programs to address common challenges experienced in rural communities across the United States. The modules in this toolkit contain resources and information focused on developing, implementing, evaluating, and sustaining telehealth programs for rural community health programs.

How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency

These policies are effective beginning March 31, 2020, and will remain in effect for the duration of the public health emergency, unless DEA specifies an earlier date. This decision tree summarizes policies adopted in response to the COVID-19 public health emergency by the Drug Enforcement Administration (DEA) to allow DEA-registered practitioners to prescribe controlled substances without having to interact in-person with their patients the policies. This decision tree is for quick reference and does not provide a complete description of all requirements.

Measuring Success in Substance Use Grant Programs: Outcomes and Metrics for Improvement

This report, the first in a series of three, examines four of the Substance Abuse and Mental Health Services Administration's grant programs that help alleviate suffering due to opioids and improve treatment quality and access. It offers recommendations about the existing reporting tools used by these programs and and proposes additional metrics and outcomes that should be considered.

Best Practices for Designing and Implementing Substance Use Disorder (SUD)-Focused Health Homes

This document provides a description of some best practices for designing and implementing a Substance Use Disorder (SUD)-focused health home state plan amendment based on the experiences of states with approved SUD-focused health home programs as required per section 1006(a)(2) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (P.L. 115-271).